Will India Extend Compulsory Licenses Beyond Anti-Cancer Drugs?
This article was originally published in PharmAsia News
Executive Summary
According to well-placed sources, the Indian government may look at areas like diabetes, hepatitis and HIV/AIDS to issue compulsory licenses, further adding to a controversy that started last year.